VALIDITY OF CREATININE CLEARANCE ESTIMATES IN THE ASSESSMENT OF RENAL-FUNCTION

被引:117
作者
LUKE, DR
HALSTENSON, CE
OPSAHL, JA
MATZKE, GR
机构
[1] HENNEPIN CTY MED CTR, DIV NEPHROL, DRUG EVALUAT UNIT, MINNEAPOLIS, MN 55415 USA
[2] UNIV MINNESOTA, SCH MED, MINNEAPOLIS, MN 55455 USA
[3] UNIV MINNESOTA, COLL PHARM, MINNEAPOLIS, MN 55455 USA
关键词
D O I
10.1038/clpt.1990.186
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In clinical practice, estimations of renal function are commonly used to calculate the appropriate dose for drugs that are renally cleared. Continuous-infusion inulin clearance (CLIN), 4-hour creatinine clearance (CLCR,m), and 24-hour creatinine clearance (CLCR,a) were measured in 109 subjects (86 men and 23 women) with varying degrees of stable renal function (CLIN, 6 to 209 ml/min) and compared with CLCR values as predicted by five equations on the basis of plasma creatinine concentrations, age, weight, and/or height. The CLCR,m, was positively correlated with CLIN (r = 0.92; p < 0.0001) but exceeded CLIN by 15% between the range of 30 and 209 ml/min (CLIN). Similarly, CLCR,a correlated well with both CLCR,m (r = 0.84; p < 0.0005) and CLIN (r = 0.84; p < 0.0001). The relative role of tubular secretion in the overall clearance of creatinine increased with declining CLIN and exceeded 40% when CLIN was below 30 nil/min. CLCR estimated by the Cockcroft-Gault and Mawer methods did not significantly differ from either CLCR,m or CLCR,a, whereas the other equations generally underestimated CLCR Among the numerous mathematical equations, CLCR as estimated by the method proposed either by Mawer or Cockcroft and Gault was the best predictor of CL., (CLIN = 1.05CLCR - 18.38 or CLIN = 1.12CLCR - 20.60, respectively; r = 0.81; p < 0.0001). The present data support the use of estimator equations proposed by Cockcroft and Gault or Mawer for rapid estimation of renal function in the clinical setting. © 1990.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 27 条
  • [1] RENAL-FUNCTION STUDIES IN MAN WITH ADVANCED RENAL-INSUFFICIENCY
    BAUER, JH
    BROOKS, CS
    BURCH, RN
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1982, 2 (01) : 30 - 35
  • [2] NOMOGRAM FOR ESTIMATING CREATININE CLEARANCE
    BJORNSSON, TD
    COCCHETTO, DM
    MCGOWAN, FX
    VERGHESE, CP
    SEDOR, F
    [J]. CLINICAL PHARMACOKINETICS, 1983, 8 (04) : 365 - 369
  • [3] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [4] GENTAMICIN THERAPY
    DEVINE, BJ
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11): : 650 - 655
  • [5] DIEM K, 1970, DOCUMENTA GEIGY SCI, P537
  • [6] DOCKTOR WJ, 1983, APPLIED CLIN PHARMAC, P349
  • [7] SUPERIORITY OF DISEASE-SPECIFIC OVER CONVENTIONAL FORMULA IN PREDICTING CREATININE CLEARANCE FROM SERUM CREATININE IN PATIENTS WITH LIVER-CIRRHOSIS
    ECHIZEN, H
    ISHIZAKI, T
    [J]. THERAPEUTIC DRUG MONITORING, 1988, 10 (04) : 369 - 375
  • [8] FJELDBO W, 1968, J LAB CLIN MED, V72, P353
  • [9] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE CONCENTRATION BASED ON LEAN BODY-MASS
    HALLYNCK, T
    SOEP, HH
    THOMIS, J
    BOELAERT, J
    DANEELS, R
    FILLASTRE, JP
    DEROSA, F
    RUBINSTEIN, E
    HATALA, M
    SPOUSTA, J
    DETTLI, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (03) : 414 - 421
  • [10] RENAL EXTRACTION OF PARA-AMINOHIPPURATE AND CREATININE MEASURED BY CONTINUOUS IN VIVO SAMPLING OF ARTERIAL AND RENAL-VEIN BLOOD
    HARVEY, RB
    BROTHERS, AJ
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1962, 102 (01) : 46 - &